Remove tag uk
article thumbnail

Oligonucleotide synthesis market to reach $16.7 billion by 2027

European Pharmaceutical Review

LGC Limited (UK). Tag Copenhagen A/S (Denmark). Alnylam Pharmaceuticals, Inc. (US). ATDBio Ltd. ( Biogen Inc. (US). Biolegio B.V. Netherlands). Biolytic Lab Performance Inc. (US). CSBIO (US). Danaher Corporation (US). Eton Bioscience, Inc. (US). Eurofins Scientific (Germany). Ionis Pharmaceuticals, Inc. (US).

article thumbnail

Risk-sharing agreements are growing at a rate of 24%

Pharmaceutical Technology

This is not the first treatment to come with a high price tag. Countries with a high willingness for performance-based models, such as the UK, saw this RSA type peak in 2019 before continually declining. million, according to GlobalData’s Price Intelligence (POLI), making it the most expensive drug in the world.

FDA 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Free access to Zolgensma curbed, says Novartis

pharmaphorum

” Zolgensma is one of the most expensive therapies available, with a price tag of around $2.1 Pause in UK access. million in the US and just under €2 million in Europe, which the company says is justified by its dramatic benefits when given as a one-shot therapy to patients with SMA. .

119
119
article thumbnail

Drug-resistant epilepsy drug Ontozry backed by NICE

pharmaphorum

Epilepsy affects more than 600,000 people in the UK and for some, seizures can be life-threatening. It is estimated that around 1,000 people die in the UK every year because of the condition. “We look forward to the full technology appraisal guidance (TAG) which is due to be published in early December 2021,” he added. .

article thumbnail

Scientists and medics turn to TikTok to reassure public on vaccine safety

pharmaphorum

One such scientist is Dr Anna Blakney (pictured above left), who is working on the COVID-19 vaccine project underway at Imperial College London in the UK and has attracted an impressive 205,000 followers. She told the BBC that her approach on TikTok is “come for the entertainment, but stay for the science.”

article thumbnail

Jolly Good/Teijin Pharma develop VR digital therapeutics for depression

pharmaphorum

In 2019 Cognitant and Addenbrook’s Hospital in Cambridge, UK piloted a programme that aimed to educate patients to improve adherence to rheumatoid arthritis medicines. It comprises more than 170 companies and employs 20,000 people across 20 countries worldwide.

Hospitals 122
article thumbnail

NICE says yes to Novartis’ multiple sclerosis therapy Kesimpta

pharmaphorum

Novartis has secured backing from NICE for its relapsing multiple sclerosis (RMS) therapy Kesimpta in the UK, just two weeks after the drug was approved by the national drugs regulator. . There are around 130,000 people with MS in the UK, with 7,000 new diagnoses a year.

Hospitals 111